Supplier

BLUEPRINT MEDICINES (NETHERLANDS), B.V.

Amsterdam · NLD

Track this recordWith Adjudera Pro, get alerted before a contract here runs out.

Awards

Total awarded

€1.5m

5 / 5 with a value

Buyers

Sectors

Group: BLUEPRINT MEDICINES BV(inferred)

USt-IdNr. DE331105665

Contracts this supplier holds that are running out

Awarded	Buyer	Winner	Contract value	Published
suministro del principio activo denominado " AVAPRITINIB 100 MGCOMPRIMIDO ORAL " para el Hospital Universitario de Gran Canaria Dr. Negrín.	Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín	BLUEPRINT MEDICINES (NETHERLANDS), B.V.	€83,973	17 Sept 2026
Avapritinib 300 MG Comp oral	Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín	BLUEPRINT MEDICINES (NETHERLANDS), B.V.	€65,979	24 Mar 2026
Avapritinib 25 MG Comp oral	Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín	BLUEPRINT MEDICINES (NETHERLANDS), B.V.	€77,975	24 Mar 2026
Lote 1	Servicio Andaluz de Salud. Hospital Universitario Puerta del Mar	BLUEPRINT MEDICINES (NETHERLANDS), B.V.	€1,239,719	23 Feb 2026
Suministro del principio activo denominado "AVAPRITINIB 200 MG".	Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín	BLUEPRINT MEDICINES (NETHERLANDS), B.V.	€71,975	13 May 2025

BLUEPRINT MEDICINES (NETHERLANDS), B.V. · BLUEPRINT MEDICINES (NETHERLANDS) BV